CD274 and non-small cell lung carcinoma: High TMB has been shown to be associated with high PD-L1, CTLA4, and CD8+ T cell infiltrates [61], as well as clinical benefit in advanced NSCLC patients that received neoadjuvant treatment with ICIs [62].